Biotech

All Articles

BioAge eyes $180M from IPO, personal placement for excessive weight trials

.BioAge Labs is eyeing all around $180 thousand in initial profits coming from an IPO and a private ...

Merck's LAG-3 combo fails colon cancer stage 3 research study

.An attempt through Merck &amp Co. to open the microsatellite steady (MSS) metastatic intestines can...

Spanish VC finalizes $200M lifestyle sciences fund

.Spain-based Asabys Allies has closed a fund of 180 million europeans ($ 200 million), money that wi...

BioAge brings in $198M from IPO as excessive weight biotech signs up with Nasdaq

.BioAge Labs is introducing virtually $200 thousand via its own Nasdaq IPO today, with the proceeds ...

Acadia delivers BMS veterinarian on board as CEO-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of notable management hirings, firings and also...

Cassava spends $40M over apparently deceiving Alzheimer's update

.Cassava Sciences has accepted to pay for $40 thousand to settle an investigation right into cases i...

Merck bags choices on Evaxion's AI-designed vaccine prospects

.Merck &amp Co. has picked up choices on pair of Evaxion Biotech vaccine applicants, paying $3.2 tho...

Enanta's RSV antiviral crushes popular tons in problem study

.Enanta Pharmaceuticals has actually linked its own respiratory syncytial infection (RSV) antiviral ...

Biogen cans SAGE-324 cooperation after essential tremor fail

.Biogen has actually conducted the final rites to its own collaboration with Sage Rehabs on SAGE-324...

AbbVie Parkinson's drug from $8.7 B Cerevel purchase scores

.On the exact same time that some Parkinson's ailment medications are actually being actually brough...